Description

Handok Inc. operates as a comprehensive pharmaceutical enterprise, providing a diverse portfolio of products. These offerings include both prescription (ETC) and over-the-counter (OTC) medications, along with medical devices and diagnostic instruments for in-vitro use. The company dedicates its efforts to several key therapeutic areas, such as cancer treatment (oncology), diabetes and metabolic conditions, rare central nervous system (CNS) disorders, and various eye ailments, among others. Beyond pharmaceuticals, Handok also offers a range of healthcare products, featuring nutritional supplements under its NatureSet and Culturelle brands, various food and beverage items, and specialized medical nutrition products. The company has entered into strategic partnerships with AUM Biosciences Pte. Ltd. and CMG Pharmaceutical Co. Ltd. These collaborations are focused on the development, production, and market introduction of CHC2014, a pan-TRK inhibitor designed for treating cancer. Founded in 1954, the organization, originally known as Handok Pharmaceuticals Co., Ltd., officially changed its name to Handok Inc. in July 2013. Its corporate headquarters are located in Seoul, South Korea.